In a variety of solid tumors, including CRC,19, 20 bladder cancer,27 non‐small cell lung cancer,28 triple‐negative breast cancer,29 and pancreatic cancer,30 CA9 has been widely confirmed as an oncogenic factor and diagnostic molecular marker. The gene discussed is CA9; the disease is familial pancreatic carcinoma.